For the quarter ending 2024-09-30, CYTH made $233,772 in revenue. -$8,832,944 in net income. Net profit margin of -3778.44%.
| Income Statement | 2024-09-30 | 2024-06-30 | 2023-12-31 | |
|---|---|---|---|---|
| Product sales | 233,772 | 123,104 | 269,101.25 | |
| Cost of goods sold (exclusive of direct and indirect overhead and handling costs) | 16,798 | 13,381 | 21,091.75 | |
| Us-gaap_grossprofit | 216,974 | 109,723 | 248,009.5 | |
| Repairs and maintenance | 3,495 | 7,964 | 3,522.75 | |
| Depreciation | 2,177 | 2,177 | 4,819 | |
| Research and development | 5,492,844 | 3,491,800 | 3,545,442.25 | |
| Board of director fees and costs | 111,281 | 111,382 | 83,817 | |
| Personnel | 843,157 | 915,569 | 845,734.5 | |
| Office and other | 640,590 | 828,578 | 290,273.5 | |
| Professional fees | 1,412,432 | 387,443 | 485,939.25 | |
| Freight and shipping | 441 | 501 | 975.5 | |
| Us-gaap_costsandexpenses | 8,506,417 | 5,745,414 | 5,260,523.75 | |
| Us-gaap_operatingincomeloss | -8,289,443 | -5,635,691 | -5,012,514.25 | |
| Ctdh_gainlossonchangeinfairvalueofconvertibledebt | -1,467,000 | -711,000 | - | |
| Lease income | 373,878 | 561,314 | - | |
| Investment and other income (expense), net | 549,621 | -195,877 | - | |
| Us-gaap_nonoperatingincomeexpense | -543,501 | - | -1,811.25 | |
| Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest | -8,832,944 | -5,981,254 | -5,014,325.5 | |
| Us-gaap_comprehensiveincomenetoftax | - | -5,981,254 | - | |
| Net loss | -8,832,944 | - | -5,014,325.5 | |
| Basic eps | -0.31 | -0.21 | -0.308 | |
| Basic average shares | 28,729,641 | 28,638,878 | 4,082,428.25 | |
null (CYTH)
null (CYTH)